Concordantly, genetic or pharmacologic inhibition of PIKfyve upregulated tumor-specific MHC-I surface expression, increased intratumoral functional CD8+ T cells, and retarded tumor progression in syngeneic mouse models. Here, CD8A is linked to neoplasm.